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Abstract
Background: WHO has recognised the need to ensure that guideline processes are transparent and evidence
based, and that the resulting recommendations are relevant and applicable. Along with decision-making criteria
that require findings from effectiveness reviews, WHO is increasingly using evidence derived from qualitative
evidence syntheses (QES) to inform the values, acceptability, equity and feasibility implications of its recommendations.
This is the first in a series of three papers examining the use of QES in developing clinical and health
systems guidelines.
Methods: WHO convened a group of methodologists involved in developing recent (2010–2018) guidelines
that were informed by QES. Using a pragmatic and iterative approach that included feedback from WHO
staff and other stakeholders, the group reflected on, discussed and identified key methods and research
implications from designing QES and using the resulting findings in guideline development. Our aim in this
paper is to (1) describe and discuss how the findings of QES can inform the scope of a guideline and (2)
develop findings for key guideline decision-making criteria.
Results: QES resulted in the addition of new outcomes that are directly relevant to service users, a stronger evidence
base for decisions about how much effective interventions and related outcomes are valued by stakeholders in a range
of contexts, and a more complete database of summary evidence for guideline panels to consider, linked to decisions
about values, acceptability, feasibility and equity.
Conclusions: Rigorously conducted QES can be a powerful means of improving the relevance of guidelines, and of
ensuring that the concerns of stakeholders, at all levels of the healthcare system and from a wide range of settings, are
taken into account at all stages of the process.
Keywords: Evidence-to-decision, guideline development, GRADE, GRADE-CERQual, QES, qualitative review, qualitative
evidence synthesis/syntheses, qualitative methods, WHO guidelines
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Background
The external generalisability of guidelines compiled by
WHO and other organisations has been a subject of de-
bate [1–3]. One of the critiques has been the lack of
consultation with guideline users and anyone affected by
guideline recommendations about the scope and setting
of priorities for guidelines. Another is that the lack of
transparency, around how and which knowledge informs
the recommendations, limits their external validity and
transferability to a range of contexts, cultures and indi-
viduals [3].
WHO has recognised the need to improve its guideline
methodology to ensure that guideline decision-making
processes are transparent and evidence based, and that the
resulting recommendations are relevant and applicable.
Hence, the WHO Handbook for Guideline Development
was produced. This stipulates that evidence of several cri-
teria is required to inform a WHO guideline recommenda-
tion in addition to evidence of the effectiveness of an
intervention [4]. These other criteria include values and
preferences, acceptability, feasibility and equity implica-
tions. Qualitative evidence can help inform these criteria.
More broadly, there is increasing interest in the use of
qualitative evidence to inform decisions in a wide variety of
sectors such as health and social care, prison care, and edu-
cation. However, until recently, the decisions made by
guideline panels about these criteria have been largely
based on the expert opinion of guideline development
groups at WHO and/or on evidence that they happen to
know about or that has been collected ad hoc, rather than
on a systematic review of relevant research [2].
A systematic review of qualitative studies, also known as
a qualitative evidence synthesis (QES), is an approach for
synthesising the findings from multiple primary qualitative
studies. Findings from QES are generally more robust and
useful than those from individual primary qualitative stud-
ies as they bring together evidence from multiple studies,
thus providing richer data than a single study can. QES can
also identify patterns in the data, explore similarities and
differences across settings, lead to a new interpretive model
or framework, and contribute broadly to a field of research.
In theory, evidence from QES can be used alongside
effectiveness evidence [4] to inform all stages of develop-
ing a guideline, including identifying the relevant inter-
ventions and outcomes at the scoping stage, synthesising
and evaluating evidence, formulating recommendations,
and developing implementation considerations. QES re-
views conducted at the scoping stage, before the guide-
line protocol is finalised, can identify broader concepts
that can shape the overall scope of the guideline. Once
the protocol is finalised, QES reviews designed to inform
evidence-to-decision (EtD) frameworks are tailored to
identify the acceptability, feasibility and/or equity of a
specific intervention within the guideline, and/or to
inform judgements about how much stakeholders might
value the outcomes associated with the intervention.
The first WHO guideline that included QES was pro-
duced by the WHO Department of Reproductive Health
and Research in 2012 [5]. Since then, this department has
published at least six more guidelines that include QES
findings [6–11], with two more in preparation (WHO:
Guidance on communication interventions to inform and
educate caregivers on routine childhood vaccination in
the African region, under review; WHO: Recommenda-
tions on digital interventions for health systems strength-
ening, under review). In these guidelines, QES were used
to inform the values and preferences, acceptability, feasi-
bility, and/or equity criteria of the respective EtD frame-
works. In two guidelines [7, 8], a priori conceptual QES
were undertaken at the scoping stage to determine what
outcomes were important to the relevant service users.
This paper is the first of a series of three on the use of
QES to inform the development of clinical and health sys-
tems guidelines, drawing on experience from relevant WHO
guidelines. The second and third papers deal with how find-
ings can be used to populate key criteria for decision-making
[12] and inform the implementation considerations of a
guideline [13] (Fig. 1). Throughout the series, we explore the
strengths and limitations of the described approaches, pro-
vide examples of what worked and what was less successful,
and make suggestions for improvements. The series is aimed
at guideline commissioners, members of guideline panels
and guideline development researchers as well as qualitative
review authors and primary qualitative researchers.
The aim of this paper
We have aimed to describe and discuss methods for
conducting a QES in the context of developing a guide-
line, so that QES findings can (1) inform the scope of a
guideline and (2) be used to develop findings for key
guideline decision-making criteria.
The paper starts with an overview of how studies are
identified for inclusion in QES reviews, and then de-
scribes the different analytical approaches used for scop-
ing reviews and developing findings.
Methods
The experiences, guidance and data presented in this
series of papers are the result of a range of processes
that have evolved over a decade of engagement with
qualitative research in the context of developing health-
care guidelines at WHO. To develop the ideas described
in the series, we used a pragmatic and iterative approach
that included the following steps:
1. WHO convened a core team of authors who had
been involved in WHO guideline technical teams
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since 2010 and in developing QES to support these
guidelines.
2. The core author team reflected on the guideline
development processes in which it had been
involved (see list below), focusing on the role of
QES findings in these processes. We also received
informal feedback on these processes from other
WHO staff involved in guideline development and
participants in several guideline training workshops
at WHO. This reflection and feedback led us to
identify the three key areas that became the focus
of a paper each in the series – how QES can inform
the guideline scope and develop findings for EtD
frameworks; how to use findings from QES to
populate the EtD frameworks; and how to use QES
findings to develop implementation considerations
and inform implementation guidance and processes.
3. The lead author for each paper then drafted an
outline for their paper, and these outlines were
discussed during a 4-day author workshop. In the
workshop, authors discussed the most important fac-
tors in the use of qualitative evidence in this context
to date and agreed on what worked and what could
be improved in the future. The outlines were then
developed into full papers, using an iterative process
of sequential writing and discussion. We also identi-
fied relevant examples from the guidelines in which
we had been involved. The core authors then
reviewed the draft to clarify the ideas and processes
described and add further examples, where needed.
4. We then circulated the draft papers to key
stakeholders to obtain their feedback on the ideas
and processes described. These stakeholders
included members of WHO guideline panels,
methodologists, guideline commissioners and
implementation experts (see Acknowledgements).
We selected examples from the following WHO guide-
lines, in the compilation of which members of the core
author team had been involved:
1. Optimising health worker roles for maternal and
newborn health through task-shifting (2012) [5]
2. Expanding health worker roles to help improve
access to safe abortion and post-abortion care
(2015) [6]
3. WHO recommendations on antenatal care for a
positive pregnancy experience (2016) [7]
4. WHO recommendations: intrapartum care for a
positive childbirth experience (2018) [8]
5. Guidance on communication interventions to
inform and educate caregivers on routine childhood
vaccination in the African Region (under review)
6. WHO recommendations on digital interventions for
health systems strengthening (under review)
All of these guidelines were health systems focused or
had a health systems component, and all used the
GRADE EtD frameworks [14]. The latter are documents
with a common structure that includes a question, an
assessment of the evidence that addresses the question,
and a conclusion; this facilitates explicit and transparent
decision-making [15] (see Additional file 1 for an ex-
ample of an EtD framework template). Examples were
selected to highlight how qualitative evidence was used
in the guideline processes described and the strategies
that we used to package this evidence for decision-
making purposes.
Fig. 1 Qualitative evidence synthesis for guidelines: overview of this series of three papers
Downe et al. Health Research Policy and Systems           (2019) 17:76 Page 3 of 12
In some cases, we have made small changes to the
wording of the examples so that they can stand alone
from the guideline text or to emphasise the issue they
are intended to highlight. We have noted in the text
where we have adapted the examples from the guidelines
listed above. The examples in this paper are derived
mainly from the antenatal and intrapartum care guide-
lines [7, 8]. Figure 2 illustrates the WHO guideline de-
velopment process.
Results
We provide an overview here of how to conduct a QES
in the context of guideline development, along with ex-
amples from QES-informed guidelines.
Review protocol
The development of a protocol is important for framing
the parameters of the review. Reviews undertaken for
guidelines are often developed with commissioners, and
sometimes also with stakeholders, to ensure relevance to
policy. This means that the period of protocol develop-
ment may be slower than for researcher-driven reviews.
Once a protocol has been agreed upon, it is good prac-
tice to ensure it is publicly available before the review
commences. This can be done by registration with a
relevant organisation, body or agency (e.g. EPOC [Effect-
ive Practice and Organisation of Care] or PROSPERO
[International Prospective Register of Systematic Re-
views]), or through publication in a journal. As in other
qualitative systematic reviews, the protocol should in-
clude the objective of the review, criteria for including
studies (types of studies, participants, settings, interven-
tions and phenomena of interest), the search strategy,
data collection and analysis, and a reflexivity statement.
Reflexivity statement
The reflexivity statement expresses the a priori views,
values and beliefs of the review authors about the sub-
ject of interest. It is intended to provide some transpar-
ency and give readers an insight into the lens through
which the authors have viewed their data. For example,
the reflexivity statement in the QES conducted to popu-
late the antenatal care (ANC) guideline EtD frameworks
states:
“In keeping with quality standards for rigour in
qualitative research, the review authors considered
their views and opinions on antenatal care as possible
influences on the decisions made in the design and
conduct of the study, and, in turn, on how the
emerging results of the study influenced those views
and opinions. All review authors believed at the
outset, that contact with formal and informal
caregivers throughout pregnancy was valuable, but
Fig. 2 The WHO guideline development process
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that formal antenatal care provision is generally over-
focused on clinical procedures and the assessment of
risk/ill-health, with too little focus on psychosocial as-
pects of pregnancy. We therefore used refutational
analytic techniques (‘disconfirming analyses’) to
minimize the risk that these presuppositions would
skew the analysis and the interpretation of the
findings” [16].
Search methods
Ideally, an initial scoping search should be conducted
prior to the framing of the guideline parameters to iden-
tify potential concepts, e.g. values and associated out-
comes that may be important to the population under
investigation. Where this has been done, the findings
from the scoping review may guide the subsequent QES
search criteria, e.g. the ANC guideline scoping review
highlighted a number of (non-clinical) aspects of ANC
that were particularly important to women (care, sup-
port and information) but that had not been initially
highlighted by the guideline development group. We
therefore included search criteria such as ‘support’ in the
search strategy for the subsequent QES designed to gen-
erate specific findings. For both searches, the search
strategies should be transparent, with clear parameters
and filters where appropriate.
Preparing an effective search strategy
In preparing the search strategy, consideration should
also be given to the following characteristics:
1) Databases – A selection of relevant databases
should be identified by the review group,
incorporating those that index studies from specific
settings, where appropriate. In the antenatal and
intrapartum care reviews, we wanted to maximise
global reach, so we utilised LATINDEX for studies
from South America, and AJOL (African Journals
Online) to pick up studies from Africa as well as
more commonly used databases such as MEDLINE,
CINAHL and PsycINFO.
2) Date range – If a range of dates is relevant to the
review objective(s) this should be identified by the
reviewers. For example, in the ANC QES, we used
2001 as a start date as this was when the existing
WHO ANC programme was introduced.
3) Types of publications – Reviewers should look for
studies utilising a qualitative research design (e.g.
ethnography or phenomenology) or qualitative
methods for data collection (e.g. focus group
interviews, individual interviews, observation,
diaries and oral histories), and which use qualitative
methods for data analysis (e.g. thematic analysis,
framework approach, grounded theory and
thematic network analysis). Mixed-methods designs
may also be relevant where findings are from the
qualitative component. Reviewers should be clear
about the documents they are looking for and deci-
sions will need to be taken about the inclusion of
grey literature, unpublished studies, commentaries,
reports, etc.
4) Language – Where appropriate, we would
encourage reviewers to include studies published in
languages other than English, particularly if the
review has a global context. However, the ability of
reviewers to translate relevant studies needs to be
considered, as additional resources may be required
here. In the reviews performed for the antenatal
and intrapartum care guidelines, we used ‘Google
Translate’ (https://translate.google.com) to perform
an initial translation and, if the study appeared to
be relevant, we identified sources within WHO to
provide a more formal translation.
Study selection
The processes used to identify studies for QES in the
context of guidelines are similar to those of other sys-
tematic reviews. Studies should be screened and selected
based on the predetermined inclusion and exclusion cri-
teria highlighted in the protocol. Careful consideration
of these criteria and their relevance to the study objec-
tives will help to focus the scope of the review and limit
the number of papers selected to a manageable amount.
Reviewers should make every effort to ensure that the
search strategy optimises the opportunity to locate the
maximum number of studies from the full range of con-
texts and participants for which/whom the guideline is
intended to apply. However, unlike the techniques used
to identify quantitative studies for systematic reviews or
meta-analyses, it is not essential to identify and include
every available relevant study. The purpose of QES is in-
terpretive rather than predictive. Important, transferable
concepts (or themes) are unlikely to change substantially
in subsequent studies once they are consistently found
in a body of papers from a wide range of participants
and contexts. The number of studies included in any
specific QES will therefore depend on the variety of con-
cepts identified, the range of sociocultural contexts of
interest to the guideline, and the degree of agreement
between studies on the emerging concepts and themes.
For the QES conducted to inform the antenatal and
intrapartum care guidelines, respectively [17, 18],
study selection was done by the review lead authors,
one of whom was an expert in the field. As these
guidelines were about healthy women receiving rou-
tine care, we excluded studies that fell outside of
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these parameters such as those including only women
with specific pregnancy complications. Where there
were doubts about specific studies, agreement on in-
clusion/exclusion was reached by consensus or adjudi-
cation by a third reviewer [15, 16].
Assessment of quality
The included studies should be subjected to a formal
quality appraisal using one of the recognised appraisal
systems for qualitative research. There is as yet no stan-
dardised tool for this process, but a modified version of
CASP (Critical Appraisal Skills Programme) was used
for the OptimizeMNH guideline QES [17, 19], whilst an
amalgamated tool, incorporating the characteristics of
several qualitative appraisal tools, was used for the ante-
natal and intrapartum care QES [20, 21]. This latter in-
strument rates studies against 11 criteria, and then
allocates a score of A–D to each study, based on the ex-
tent to which it demonstrates credibility, transferability,
dependability and conformability. Studies scoring D,
which have “[s]ignificant flaws that are very likely to
affect the credibility, transferability, dependability and/or
confirmability of the study”, are excluded on the grounds
of methodological quality.
Sampling
In the examples discussed in this paper, the number of
included studies ranged from 35 to 53 [17, 19]. When
there is a large number of included studies or a dispro-
portionate number of studies from a particular country
or context, reviewers may wish to select a sample. A
‘large number’ is difficult to quantify and will, to a cer-
tain extent, depend on the emerging themes and con-
cepts as well as the resources available and the
timeframe required to complete the review. Reviewers
should seek to ensure that no one sampling system af-
fects the overall quality of the review by introducing re-
viewer bias. In the OptimizeMNH reviews, the authors
“utilized purposive sampling in order to arrive at a group
of studies that provided geographical coverage” [17, 19].
By achieving this coverage, the authors hoped to ensure
a greater variation in contexts and thereby greater con-
ceptual diversity. There are a number of sampling
methods as well as a variety of approaches, and re-
viewers should be aware of the different techniques be-
fore deciding which to use [17, 18, 22, 23].
Demonstrating rigor in study selection
For both types of QES reviews, the standard PRISMA
flow diagram should be presented to demonstrate the
decisions that led to the final study inclusion (see Add-
itional file 1 for a PRISMA flow diagram from the intra-
partum care review).
QES at the guideline scoping stage
Scoping is the first stage of guideline development. It entails
agreement with stakeholders about which interventions
and which outcomes are most significant for the review.
The process is informed by what evidence already exists
(usually in the form of systematic reviews of existing rando-
mised trials of effectiveness) as well as by what interven-
tions are most likely to influence the health and well-being
of the target population. Decisions about critical and im-
portant outcomes that will underpin the recommendations
in the guideline must take into account what outcomes
have been measured in the relevant systematic reviews of
effectiveness as well as those that are important in practice
for the guideline stakeholders, including clinical or policy
experts, health professionals and service-users.
Although stakeholders with experience in practice or in
health system development and implementation provide
important expertise regarding outcomes that matter at a
broad population level, patients and service-user groups
have been concerned about a lack of attention to out-
comes that matter to them directly. For example, for some
years, pregnant and child-bearing women have levelled
the critique that, whilst most women and babies are
healthy, the standard outcome measures for maternity
care interventions tend to be focused on pathological out-
comes. In recognition of the importance of going beyond
just surviving the consequences of pregnancy and child-
birth, the United Nations ‘Survive, Thrive, Transform’
agenda has shifted the perspective of maternity services
from an emphasis on only reducing mortality and morbid-
ity to one that is about both survival and well-being [24].
The scoping process for the recent WHO antenatal and
intrapartum care guidelines recognised the need to ex-
pand expert professional consideration of relevant out-
comes to include the views and experiences of child-
bearing women [7, 8]. Based on this change of focus, two
scoping reviews of what matters to women in relation to
pregnancy and childbirth, respectively, were conducted to
inform these guidelines [18, 25].
Methodology of the scoping reviews for WHO antenatal
and intrapartum care guidelines
The intention of these scoping reviews was to find out
what mattered to women socially, psychologically, emo-
tionally and physically, independent (as far as possible)
of their experience of local maternity services. We used
established methods for the synthesis of qualitative data
[26]. These are extensively described in the primary out-
puts of the scoping reviews [18, 25] and in methods pa-
pers relating to qualitative synthesis [16, 26, 27]. A
summary of the qualitative synthesis methods used is
given in Box 1; we used ‘meta-ethnography’ as the syn-
thesis technique [16].
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Findings from the scoping reviews
The themes emerging from the data in the included
scoping reviews led to ‘line of argument’ syntheses (Box
2). A robust line of argument is more than the sum of
the parts of the review. It has high theoretical transfer-
ability beyond the specific included studies, and so it is
likely to be applicable in a wider range of settings and
circumstances. For both the antenatal and intrapartum
care guidelines [18, 25], the lines of argument derived
from the scoping reviews were used to inform and direct
the philosophical framing of the guideline recommenda-
tions. The findings illustrated that what matters to
women around the world in relation to both pregnancy
and childbirth is both safety (physical, clinical, psycho-
logical and emotional) and a positive experience. These
components were then summarised into a single com-
posite outcome for each review, termed ‘positive preg-
nancy experience’ and ‘positive childbirth experience’,
respectively. Box 2 provides more detail on the compo-
nents of these outcomes. It shows that the positive ex-
perience concept captures factors that are part of the
standard outcomes dataset for maternity care effective-
ness reviews, i.e., mortality and morbidity. However, they
also encompass factors that map directly into the ‘Sur-
vive, Thrive, Transform’ agenda such as psychosocial and
emotional outcomes in both the short and longer term.
The value of the novel ‘positive experience’ outcomes
The overall notion of a positive experience (of both
pregnancy and childbirth) has never been part of stand-
ard outcomes assessment for studies of maternity care
interventions. The nearest equivalent is ‘satisfaction’.
However, satisfaction is known to be a poor measure of
healthcare experience and it does not encompass the
multiple dimensions of positive well-being identified in
Box 2. In recognition of the importance of these find-
ings, both the antenatal and intrapartum care guideline
panels adopted the new positive experience outcome for
their effectiveness reviews. Since it did not exist before
the guideline process, there were no pretested measure-
ment tools associated with it, so none of the effective-
ness trials included in the review captured it directly (if
at all). However, it was included to ensure that any proxy
measures (including satisfaction) used in the eligible tri-
als were identified and flagged, and as a driver for the
development of positive experience outcome measures
for use in future trials and reviews.
The notion of a positive experience was also adopted by
the guideline development groups as the overarching
guideline concept. It even influenced the guideline title
‘WHO Recommendations on Antenatal Care for a Positive
Pregnancy Experience’ [7]. For the ANC guideline, further
framework analysis conducted during the scoping QES
Box 1. Summary of qualitative synthesis methods used
for the QES at the guideline scoping stage
Step 1. The included papers were examined, and an index paper
was selected that best reflected the focus of the review.
Step 2. The themes and findings identified by the authors of
this paper were entered onto a spreadsheet, to develop an
initial thematic framework.
Step 3. The findings of all the remaining papers were then
mapped into this framework, which continued to develop as
the data from each paper were added. This process included
looking for what was similar between papers (‘reciprocal
analysis’) and what contradicted (‘disconfirms’) the emerging
findings (‘refutational analysis’). For the refutational process, as
each paper was added to the analysis, we consciously looked
for data that could disconfirm our emerging themes or our prior
beliefs related to the topic of the review. If any disconfirming
data were found, the themes were amended, so that they
continued to capture all the data from the papers we had
already analysed as well as taking account of the new insights.
Step 4. All the themes were translated (or synthesised) into a
‘line of argument synthesis’, based on theoretical concepts that
explain the data at a conceptual level.
Box 2. Line of argument syntheses from two scoping
QES to inform WHO guidelines
1. What matters to women: a scoping review to identify the
processes and outcomes of ANC provision that are important to
healthy pregnant women [28]
“Women want and need a positive pregnancy experience, including
four subthemes: maintaining physical and sociocultural normality;
maintaining a healthy pregnancy for mother and baby (including
preventing and treating risks, illness and death); effective transition
to positive labour and birth; and achieving positive motherhood
(including maternal self-esteem, competence, autonomy).”
What matters to women during childbirth: a systematic
qualitative review.
2. “For most childbearing women across the world, there is
inherent value in being able to use one’s own physical and
psychosocial capacities to labour, and to give birth to a healthy
baby, even when the process is unpredictable and painful. Beliefs
about what matters to women are influenced by familial
experiences, and local cultural norms and values. The capacity for
women to enact what matters to them is affected by anticipated
or actual encounters with maternity care staff and services,
including the use of desired, required, and/ or feared childbirth
interventions.”
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informed the WHO vision for ANC and the overarching
aim of the new WHO ANC model, which is “to provide
pregnant women with respectful, individualised, person-
centred care at every contact, with implementation of ef-
fective clinical practices (interventions and tests), and
provision of relevant and timely information, and psycho-
social and emotional support, by practitioners with good
clinical and interpersonal skills within a well-functioning
health system” [7].
The lines of argument from these scoping reviews also
highlighted certain stakeholder beliefs and values that
had been overlooked by the respective guideline devel-
opment groups. For example, in the scoping review for
the intrapartum care guideline [18] women’s concerns
about pain and pain-relief during labour were a signifi-
cant finding and one which had been excluded from the
initial guideline development discussions. Questions
relating to pain-relief options were subsequently
added in the guideline development process and in-
corporated into the final guideline [8]. Similarly,
guideline questions were added to the ANC guideline
development process on interventions for physio-
logical symptoms, midwife-led continuity of care and
group ANC, following the QES findings on ‘what
matters to women’ about ANC [25].
QES to develop summary of findings statements for
decision-making (EtD Frameworks)
Whereas a priori scoping reviews are broad and concep-
tual, qualitative reviews to develop findings for key EtD
framework criteria within the guideline protocol are di-
rected by the types of interventions that are being exam-
ined. Therefore, the approach to synthesising data from
included studies for this purpose should be more fo-
cused than for scoping reviews.
Data analysis
Once the included studies have been identified and ap-
praised for methodological limitations, the analytic
phase can begin. The main purpose of an EtD-orientated
QES is to generate a series of findings from the included
data, which are directly focused on interventions ad-
dressed in the guideline, assessed for confidence and tai-
lored towards acceptability, feasibility and equity, and
the values that stakeholders attribute to the outcomes
associated with the intervention. The findings are then
added to the guideline EtD frameworks, prior to guide-
line panel consideration, as discussed in the second
paper in this series.
For the antenatal and intrapartum care QES, as for
the scoping QES methods, we firstly identified an
index paper and built the themes with the data from
subsequent papers (Box 1). Unlike for the scoping
QES, we then unpacked the detail of the final themes
into short statements (findings). These were then sub-
ject to appraisal [28] to determine the degree of con-
fidence placed on each finding (Table 1). For the
appraisal process, we used a relatively new technique,
Confidence in the Evidence from Reviews of Qualita-
tive research (CERQual), part of the GRADE tools for
appraising findings from systematic reviews. The
CERQual tool includes four appraisal components
(methodological limitations, relevance, coherence and
adequacy) and each finding is assessed against these
criteria before being given an overall grade (high,
moderate, low or very low confidence). For more in-
formation on the [ of CERQual, readers are referred
to a recent series on the topic [29–35].
Tailoring QES findings statements for EtD frameworks
Once the review findings for a QES have been generated,
reviewers should start drafting short statements that de-
scribe the findings data. The statements associated with
each finding need to be framed with end-users and key
stakeholders in mind, and the review team should con-
sider what these potential users would want to know [15].
Each finding statement should be clear and concise
and accurately capture the meaning of the underlying
data that contribute to it. Each one should include an as-
sessment of confidence in the contributing evidence. A
finding statement should be developed iteratively so that
key concepts can be clarified and explored, but it should
Table 1 Themes, short-form Summary of Findings, and CERQual ratings for the WHO antenatal care guideline. The Summary of
Findings that emerged from both women and provider data on their views and experiences of antenatal care
Theme Short-form Summary of Findings by CERQual rating
High confidence Moderate confidence Low/very low confidence
Sociocultural context Pregnancy seen as a normal event Cooperation with influential
community membersa
Gender of healthcare provider
Service philosophy, design and
provision
Indirect cost of services Poor infrastructure
Long waiting times
Staff traininga
Staff corruptiona
What matters to women and staff Authentic and kind staff
Antenatal care as a source of
knowledge and information
Continuity of care Attraction of specific components
of antenatal carea
a From providers only
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be no more than a few sentences in length. For example,
in the short form of findings represented in Table 1,
women and service providers consistently reported on a
variety of issues relating to the influence of others, indir-
ect cost of services, time spent with the professional or
service user (depending on the perspective), flexibility of
appointments, and continuity of care.
The full finding statement for ‘Indirect cost of services’,
for example, was “In the vast majority of countries ANC
is provided free of charge but in many contexts the indir-
ect costs associated with transport to and from the clinic,
the purchase of additional medicines and the potential
loss of income associated with clinic attendance all act
as a barrier to engagement with ANC” (high confidence
in the evidence).
Readers should bear in mind that there may be contra-
dictory review findings on the same or similar issues. Re-
viewers need to strike a balance between splitting issues
emerging from the synthesis into multiple review find-
ings, resulting in findings that are no longer useful to
end users and do not fully represent the phenomenon of
interest, and generating a smaller number of broad find-
ings that oversimplify or fail to adequately capture varia-
tions across different contexts. For example, in the QES
on experiences of intrapartum care, women talked about
the importance of the birthing environment. Sometimes,
these views were expressed positively (e.g. health facil-
ities were described as clean and safe) and, in other in-
stances, they were expressed negatively (labour wards
were deemed to be unhygienic, poorly maintained and
overcrowded). These opposing views could be reflected
as two separate statements but, in this case, following
discussions between the review authors, the finding
statement was captured under a broad heading that en-
capsulated both sets of experiences, i.e. the need for a
safe and secure environment: “Women highlighted the
importance of having a safe, clean and relatively private
space to give birth and emphasized the importance of
having medical equipment on hand should the need
arise. Where these criteria weren’t in evidence, women
felt unnerved by the lack of space, poor hygiene, state of
disrepair and the loss of dignity associated with giving
birth in overcrowded delivery rooms.” The decision to re-
tain the integrity of opposing views as separate and dis-
tinct may depend on prior knowledge of the phenomena
and/or the relative importance in different contexts or
amongst different population groups. For example, in
the QES on women’s experiences of ANC, some women
reported that providers could be rude, disrespectful and
occasionally abusive, while others highlighted qualities
of care, compassion and kindness amongst providers. In
theory, these divergent views could be merged under a
heading like ‘staff attitude’ but, on closer inspection, it
became clear that the women reporting rude and abusive
behaviour were generally located in low-income settings,
whilst those discussing kindness were largely resident in
high-income countries. We therefore took the decision
to express these findings separately as ‘Rude and abusive
staff ’ and ‘Authentic and kind staff ’.
Figure 3 provides an example that illustrates the jour-
ney of an individual quote from a primary paper through
the guideline development process. Approaches for
populating GRADE EtD frameworks with qualitative
findings are covered in the next paper in this series [12].
Demonstrating rigor in study analysis (for both types of
QES)
As for all systematic reviews, the characteristics and
quality assessment of the included studies should be pre-
sented in the review, along with a summary of the rea-
sons for excluding studies. A table listing the review
themes and/or a Summary of Findings should be in-
cluded, which lists the codes for the included studies
that contributed to each theme or finding. For each find-
ing included in the Summary of Findings, the CERQual
rating should also be listed alongside, with reasons for
downgrading if this has occurred. A finding may be
downgraded if it fails to meet any of the four appraisal
components (methodological limitations, relevance, co-
herence and adequacy) inherent in the CERQual tool.
This can also be done for thematic findings. Examples of
this approach can be found in the QES papers on
women and health provider experiences of antenatal and
intrapartum care [16, 27].
Discussion
In this paper, we have tried to describe and discuss the
methods for conducting a QES in the context of devel-
oping a guideline and have explored how QES findings
can inform the scope of a guideline and be used to de-
velop findings for key guideline decision-making criteria.
The limitations of this approach to guideline develop-
ment include the difficulty of determining at what stage
in the guideline development process the review should
be undertaken, and the additional resources required to
conduct the review rigorously. In our experience, the
process of undertaking qualitative reviews (particularly
scoping reviews) identified factors that were important
to stakeholders but that had not been considered in the
prior guideline group agreements about which effective-
ness reviews to include. This suggests that undertaking
the qualitative reviews earlier might have improved the
scope of the final guidelines. For other guidelines, it be-
came clear that some sub-questions could have benefited
from more focused qualitative reviews earlier in the
process. For example, for the ANC guideline, separate
QES reviews could have been conducted of women’s ex-
periences of nutritional, maternal and fetal assessment,
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preventive measures, and physiological and health sys-
tems interventions. This lesson was learned for the
intrapartum care QES, in which ‘mini-reviews’ of the
qualitative evidence in specific areas (such as episiot-
omy) were undertaken as the guideline development
process progressed. The need for these kinds of supple-
mentary reviews is not always predictable at the
commissioning stage, and therefore also has resource
implications.
The benefits of committing additional resources to
the examination of qualitative evidence include the
potential for reframing guidelines to fit with real-
world concerns and issues for key stakeholders. It
also provides an opportunity to maximise the impact
of the resulting recommendations in practice for
those funding, providing and using services. In the
case of the guidelines that underpin this series, the
inclusion of qualitative data encouraged the guideline
panels to pay particular attention to the experiences
of women, providers and policy-makers at all stages
of the process, from the overall values that framed
the guidelines, through to implementation consider-
ations and design of implementation tools and pro-
cesses. This observation aligns closely with the
hypothesised benefits of both realist and implementa-
tion science, in which the interest is to understand
not just what works, but how it works (best), in what
contexts, and for which individual(s) and groups [36].
Fig. 3 The journey of qualitative data – how data from primary qualitative studies informs guideline recommendations
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Beyond these practical considerations, in our experi-
ence with two of the included guidelines [7, 8], the in-
clusion of an a priori scoping review changed the focus
of the guideline dramatically. In both cases, this was a
shift from an almost exclusive intention to reduce path-
ology, towards a need for maternity care to also catalyse
positive maternal, newborn and family experiences. This
legitimised the inclusion of effectiveness reviews on
topics such as respectful care, companionship in labour
and continuity of midwife care, alongside interventions
such as pain-relief options.
Future methodological research in this area could in-
clude an examination of the degree to which qualitative
review findings shape the scope of guidelines, inform the
interventions to be included and impact on the informa-
tion given to panel members, how this information is re-
ceived and translated into recommendations, and the
impact of implementation in practice. Cost-effectiveness
considerations should also be examined, particularly in
relation to the levels of skills and experience needed in
qualitative review teams, and the degree to which quali-
tative reviews can be iteratively commissioned as the
need for new information emerges from the work of spe-
cific guideline development groups.
Conclusions
A guideline should aim to be as relevant as possible to
those who are affected by the recommendations, includ-
ing health service users, care providers, funders and ser-
vice managers. The scope of the guideline should,
therefore, reflect the needs of stakeholders. Many guide-
line development groups include representatives of the
groups most affected by the recommendations such as
people living with particular health or social issues.
Whilst the views of these representatives are important,
they are unlikely to represent all groups affected, par-
ticularly for global guidelines such as those produced by
WHO. Members of guideline development groups, such
as service providers and academics, are not always the
best judges of what matters to patients or other service
users. QES findings are, therefore, a good source of in-
formation about what matters to different groups of
people who may be affected by a guideline.
In this paper, we have described how QES can influ-
ence the scope of guideline development and inform the
criteria for decision-making in the context of healthcare
guidelines. We have shown the importance of initial
conceptual reviews at the scoping stage for determining
meaningful outcomes and prioritising which interven-
tions are to be included. As part of our practical guide
for those who will contribute QES reviews to future
guidelines, we have provided examples of good practice
in undertaking and interpreting QES reviews as well as
insights into the potential pitfalls. Our experience has
shown that rigorously conducted qualitative reviews can
be a powerful means of improving the relevance of
guidelines and ensuring that the concerns of stake-
holders, at all levels of the healthcare system and from a
wide range of settings, are taken into account at all
stages of the process.
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